Cellivate Technologies Secures $1 Million in Seed Funding to Revolutionize Cell Culture and Biomanufacturing

Date:

Biotech startup Cellivate Technologies has successfully raised $1 million in its seed funding round, led by Antler and supported by Venture Catalysts, Hatcher+, and We Founder Circle.

The funding will be directed towards advancing research and development, scaling up production of its pioneering products, and expanding its market presence. Founded by Viknish Krishnan Kutty, Cellivate Technologies is focused on overcoming significant challenges in cell culture and biomanufacturing.

The company’s flagship innovations include cutting-edge microcarriers designed to enhance cell growth scalability and a novel cell-based serum that aims to replace traditional fetal bovine serum. These advancements address both efficiency and ethical concerns in cell culture processes.

Market analysis predicts that the cell culture market, including microcarriers and serum, will reach $33 billion by 2030. Cellivate Technologies’ solutions are poised to reduce costs, enhance efficiency, and minimize reliance on animal-derived products, contributing to a more sustainable and ethical biomanufacturing landscape.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

HR leaders ready to shape India’s future workforce – XLRI and Leadup Universe seminar in Pune

Mumbai, 06th November: The increasing global demand for up-skilled HR Leaders...

How to use Cold Prospecting to Generate More Leads

Sales prospecting can be daunting, requiring organizations to discover...

5 Tips to Improve Your Chances of a Successful Personal Injury Case

Accidents are pretty common in New Orleans, especially during...

Viraa Care Secures $108K in Pre-Seed Funding to Expand Global Reach and Nutrition Courses

Chandigarh-based health-tech platform Viraa Care has successfully raised $108,000...